Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes
NCT06854861Phase 2Terminated
- Sponsor
- St. Olavs University Hospital
- Start
- Apr 2025
- Primary completion
- Feb 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of glucagon in type 1 diabetes mellitus (T1D) (2 arms), sponsored by St. Olavs University Hospital. Primary endpoints: Area under the glucose consumption curve at 30 months and Area under the insulin curve at 30 months. Started Apr 2025; status: terminated.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06854861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06854861.